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The major thrust of the article by Fincher et al. [1997]
appears to be an attempt to establish specific quantitative
results of single photon emission computed tomography
(SPECT) scans as criteria for differentiation of individuals
with solvent-induced toxic encephalopathy from ‘‘normal’’
individuals. The article fails utterly in this attempt for a host
of reasons, any one of which would be fatal to the effort. We
highlight some of these reasons below.
1. The study purports to investigate 25 subjects with a
history of mixed solvent exposure, and who met selection
criteria which ‘‘paralleled the Swedish standard for clinical
cases of solvent induced toxic encephalopathy.’’Five criteria
are listed, and the article by Edling et al. [1990] is cited. In
the article by Edling et al., all subjects had ‘‘at least 10 years
of verified occupational exposure to organic solvents’’ (p
76). Themeandurations of solvent exposure in the study by
Edling et al. ranged from 23 to 26 years. However, the
longest reported duration of alleged solvent exposure in the
present study was for subject number 5, who was listed as
having had only nine years of exposure. Fully 15 of the
subjects were reported to have had exposure durations that
were one year or less, seven of whom had alleged exposures
lasting no more than two days!
Clearly, none of the ‘‘cases’’ chosen for the study met
the criteria of Edling et al. [1990]. Such brief opportunities
for exposure do not even come close to what is typically
described in the medical literature among subjects with
alleged chronic solvent-induced toxic encephalopathy. As in
th study by Edling et al., solvent exposure histories
described in such cases usually involve at least two or three
decades in occupations which are known to provide opportu-
nity for significant solvent exposure. Since none of the
subjects in the present study met the exposure criteria for
solvent-induced toxic encephalopathy, there is no scientific
foundation for the conclusions in the study regarding
SPECT findings for this clinical condition.
2. In addition to unacceptably short durations of expo-
sure, many of the descriptions of ‘‘exposure incidents’’ (see
Table IV) appear to have involved minimal, if any, exposure
to solvents and thus are questionable in terms of producing
any chronic neuropsychological effect (Case 16 — ‘‘Occupa-
tional exposure from office renovation’’ for one month; Case
17 — ‘‘Occupational exposure in a ’tight’ or toxic building’’
for 1.5 years). Furthermore, we suspect that if properly
questioned most of the ‘‘controls’’ in the study would also
report similar histories of trivial opportunities for solvent
exposures. Thus, using the authors’ criteria for defining
‘‘exposures,’’ the controls would not be truly unexposed.
Hence, there is no foundation for alleging that differences in
SPECT scan results are related to such exposures.
3. The 25 subjects selected as cases for inclusion in this
study had their blood tested for a variety of solvents (see
Table III for listing). All 25 cases reportedly had detectable
levels of two or more of the chemicals for which testing was
performed. These results are problematic for a number of
reasons. First, the temporal relationship between the alleged
exposures and time of blood sampling is not specified,
making these results uninterpretable as biological indices of
exposure to solvents, or measures of ‘‘bioaccumulation of
solvents.’’ Second, the concentrations of chemicals mea-
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sured in the blood are not stated. It is well known that all
people in modern urban societies have detectable blood or
breath levels of a wide variety of exogenous organic
materials, including many of the chemicals listed in Table III
of the article [see, for example, Ashley et al., 1996; Wallace
et al., 1986, 1988]. Third, there is no indication that the
controls were tested for the same chemicals. Moreover, the
testing performed on the cases apparently was not blinded as
to ‘‘case’’ vs. ‘‘control’’ status. There also appears to have
been no consideration whatsoever to distinguishing markers
of ‘‘exposure’’ from markers of ‘‘disease.’’ Since the con-
trols were not tested for the same organic chemicals in their
blood, it is impossible to draw any conclusions as to whether
differences in SPECT results are related to differences in
blood solvent levels.
Furthermore, the descriptions under ‘‘Exposure inci-
dents’’ are not consistent with the chemicals listed under
‘‘Solvents detected in blood’’ (see Table IV). For example, in
Case 8 the ‘‘Exposure incident’’ involved trichloroethylene
(TCE) used by a mechanic to clean parts, and yet, TCE is not
listed under ‘‘Solvents detected in blood.’’ Instead, six
structurally different organic materials are listed (toluene;
1,1,1-trichloroethane; trimethylbenzenes; 2-methylpentane;
3-methylpentane; n-hexane). We see no relevance of these
other solvents to the alleged exposure, and such results
suggest that the solvent exposure incidents described in this
report have no relationship to solvents measured in the
blood. If the authors have a scientific rationale to tie the
chemicals under ‘‘Exposure incidents’’ to ‘‘Solvents de-
tected in blood,’’ they should present this in the Methods or
Discussion sections. Otherwise, data presented in Table IV
are uninterpretable.
4. The authors intended to minimize the potential
effects of extraneous medical and lifestyle variables (p 6,
first column) on SPECT results. To do so they excluded from
the study controls who had a history of concussions, head
injuries, loss of consciousness, seizures, chronic pain condi-
tions, illicit drug use, adverse reactions to household chemi-
cals, or breast implants; and those who were current
smokers, users of medications that altered cerebral blood
flow, heavy consumers of caffeinated beverages, consumers
of alcohol, and consumers of artificially sweetened bever-
ages. This extraordinary list of exclusionary factors resulted
in 74% of candidate controls being excluded from the study
(in addition to an unstated number of candidates who were
eliminated by a preliminary discussion with the investiga-
tors). What is most remarkable about this rigorous exclusion-
ary policy is that none of these exclusionary criteria were
applied to the cases. Thus, differences in SPECT results
between the cases and the controls may be due to any
combination of these factors that were admissible in cases
and inadmissible in controls. This is an egregious example
of selection bias, and would also exacerbate spectrum bias
[see Ransohoff and Feinstein, 1978].
5. The authors apparently misunderstand the concept of
confounding and sought to dismiss the possibility of con-
founding by age through statistical tests of significance [see
Rothman, 1986; Hernberg, 1996]. On page 8 they discuss
t-tests in which counts of late phase tracers among the
youngest and oldest subjects were compared. It should be
noted that the data presented by the authors in Table II show
a 31% increase in SPECT counts with increasing age and
that some of the t-tests were marginally significant until they
were subjected to a Bonferroni correction procedure. The
authors dismiss this obvious age effect, stating ‘‘These
quantitative analyses suggest that correction for gender and
age within the 25- to 45-year band is unnecessary.’’ The
issue they did not address, and which is central to the
validity of their findings, is whether age confounds the
association between SPECT results and case status. Here,
they fail to provide the age distribution of the cases which
would allow the reader to see if the cases and controls are of
comparable ages, and they fail to perform any analyses in
which age is controlled, which would reveal the extent to
which the SPECT results are explained by age.
6. The article states that ‘‘Patients with detected levels
of both pesticides and solvents were disqualified, due to the
unknown neurotoxic effect of the pesticide’’ (p 9). The
article does not provide any description of the panel of
pesticides for which testing was performed. However, none
of the cases were alleged to have had clinically significant
exposure to pesticides, so the scientific relevance and
application of this exclusion criterion is unclear. Also, many
pesticides are well known to be ubiquitous in the environ-
ment, and to be measurable in the blood of almost all
humans on the planet (e.g., dichlorodiphenyltrichloroethane,
or DDT, or its metabolic derivatives). Was detection of DDT,
or DDT metabolites, used as an exclusionary criterion?
Which pesticides, or other chemicals, were used to exclude
subjects and, most significantly, why didn’t the controls
have similar measurements performed (it is probable that
controls would have demonstrated a similar pattern of
results)?
7. SPECT testing was not performed or reported in an
interpretable manner. In the current paper, SPECT data
analysis was performed using raw counts of reconstructed
images. Raw counts of Tc-99m HMPAO SPECT images,
however, do not necessarily represent quantitatively either
cerebral blood flow or brain metabolism, due to the follow-
i g reasons. After intravenous injection, the tracer is diluted
in the venous system and cardiac chambers. Even though a
similar amount of Tc-99m HMPAO (mean 26.1 mCi) was
i jected, arterial input concentration to the brain would have
been variable across subjects because of normal variation in
the initial distribution volumes which are independent from
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either cerebral blood flow or metabolism. There was no
measurement of arterial concentration of the injected tracer
nor proper metabolite measurement provided in the current
study, which makes quantitative estimation of cerebral blood
flow or metabolism impossible.
Some authors normalize raw counts to reference regions
(such as a global count) to partially overcome the lack of
such measurements [e.g., Payne et al., 1996], but this
approach was not used in the current study. In addition, early
images obtained during the first two minutes contain not
only cerebral blood flow information but also cerebral
vascular blood volume and some back-diffusion from radio-
activity delivered earlier within the first two minutes. A
delay between the start of injection to the arrival of the
injected tracer to the brain would also be variable among
subjects, which exerts an additional uncertainty in pixel raw
counts on early images.
Raw counts on delayed images are similarly affected
with the initial plasma concentration of the tracer, which is
independent from either cerebral blood flow or metabolism
and radioactivity in the vascular blood volume as well.
SPECT image acquisition and reconstruction methods were
not described sufficiently (i.e., the number of projections,
attenuation correction method), which makes replication of
the current study difficult. Quantitative analysis of cerebral
blood flow measured with Tc-99m HMPAO has to take
account of such multiple factors carefully [e.g., Murase et
al., 1992], and has been discussed vigorously in various
settings in the research community [e.g., Rattner et al.,
1991]. Unfortunately, the analysis employed in the current
paper does not involve any ‘‘quantitative’’ technique in this
regard nor provide information necessary to estimate spe-
cific parameters such as cerebral blood flow. In addition,
‘‘region-of-interest’’ analysis used in this study was not
described specifically (e.g., what part of the ‘‘frontal’’ lobe is
included in analyses?). When estimating hemispheric or
global counts, simple averages of multiple regions were
calculated (Tables I, II, and VII). Consequently, the averaged
values were biased by smaller structures, such as the basal
ganglia and thalamus, whose values are more prone to
partial volume effects on SPECT images. Hence, conclu-
sions in the present paper based on functional brain SPECT
imaging results are suspect and cannot be used as a basis for
concluding that there are abnormalities in any patient group.
In summary, this study was poorly designed and ex-
ecuted and the results are presented inadequately. There are
numerous flaws that create confounding or bias and the
conclusions are not supported by the data presented. In our
opinion, the weaknesses in this study are so serious and
glaringly obvious that it cannot be relied upon for any
medical or scientific purpose.
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